KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
93,527,014
Share change
+17,028,053
Total reported value
$1,190,054,374
Put/Call ratio
98%
Price per share
$12.73
Number of holders
154
Value change
+$214,191,008
Number of buys
107
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q1 2015

As of 31 Mar 2015, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,527,014 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, FMR LLC, Sectoral Asset Management Inc, OAK RIDGE INVESTMENTS LLC, STATE STREET CORP, Camber Capital Management LLC, BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors. This page lists 154 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.